Amryt Pharma plc reaffirmed revenue guidance for fiscal year 2022. For the year, the company is reaffirming revenue guidance for fiscal year 2022 in the range of $260 million - $270 million which represents growth of 17% to 21% on fiscal year 2021.
1st Jan change | Capi. | |
---|---|---|
-1.41% | 90.85B | |
-1.05% | 39.02B | |
-11.20% | 33.46B | |
+61.85% | 26.38B | |
-20.75% | 14.51B | |
-6.35% | 13.22B | |
-11.42% | 11.65B | |
-47.67% | 10.57B | |
+5.99% | 9.23B |